About NYR
Nyrada Inc (NYR) is a clinical-stage biotechnology company focused on the discovery and development of small-molecule therapies, specifically targeting Transient Receptor Potential Canonical (TRPC) ion channels.
Find out what a historical investment in Nyrada would be worth today using our NYR stock calculator.
Market Capitalisation
$135M
Price-earnings ratio
-18.07
Dividend yield
-
High today
$0.52
Low today
$0.50
Open price
$0.50
52-week high
$1.44
52-week low
$0.29
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in NYR
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in NYR on Stake
- Buy NYR from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
NYR related stocks